Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating ...

For decades, the United States has led the world in developing groundbreaking medications that allow patients to live longer and healthier lives. Despite these contributions, American families pay ...

The creation of this article included the use of AI and was edited by human content creators. Read more on our AI policy here ...

Analysts expect earnings of $1.61 per share on revenue of $2.21 billion for the quarter ended December. Those figures represent a sharp sequential decline from the third quarter, when Biogen posted $2 ...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy Traumatic brain injuries affect more Americans each year than ...

While there is no cure for ALS, there have been about 65 rare cases where patients regain all, or nearly all, of their lost ...

Dr. Shune highlights that the growing availability of FDA-approved agents with distinct and complementary mechanisms has ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, in collaboration with President Trump's administration, announced new patient access pathways to make its ...

Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that its software solution, ...

ARLINGTON, Va., Feb. 3, 2026 /PRNewswire/ -- The ALS Association today applauded the reintroduction of the ALS Better Care Act bipartisan legislation to expand access to high-quality multidisciplinary ...

International equities delivered solid gains in the fourth quarter to cap one of the best years for overseas stocks in decades. Read more here.